Financials
- Market Capitalization 20.45 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4608 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.37 USD | +4.87% | -2.87% | +0.42% | +160.44% | 20.41 M USD | ||
| 4611 | NXTC NextCure, Inc. - Common Stock | 6.10 USD | -7.29% | +250.57% | +196.12% | -53.44% | 22.03 M USD | ||
| 4626 | LGVN Longeveron Inc. - Class A Common stock | 0.64 USD | +3.23% | -3.03% | -18.99% | +12.03% | 19.93 M USD | ||
| 4630 | LPCN Lipocine Inc. - Common Stock | 2.38 USD | +3.03% | -5.56% | +3.93% | -17.93% | 19.62 M USD |